EVUSHELD

Medicinal product

(Invented) name

EVUSHELD

Active substance (s)

Tiksagevimabas+Cilgavimabas

Strength

150 mg + 150 mg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J06BD03, tixagevimab and cilgavimab

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2022-03-25

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1.5 ml
Tiksagevimabas	150 mg
Solution for injection	1.5 ml
Cilgavimabas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108307	94411	1094411	flakonas	1,5 ml N2 (1+1)		Receptinis	EU/1/22/1651/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-03-25	Registruotas